With the introduction of genAI tool Elsa at the FDA in June, the technology is playing a greater role in the medical device review process.

AI was supposed to boost drug discovery, but progress has stalled. Learn why the hype hasn’t delivered and what needs to ...

Eli Lilly & Company (NYSE: LLY) ranks among the best non-tech stocks to buy according to billionaires. Eli Lilly & Company ...

Investing.com -- Maia Biotechnology Inc (NYSE: MAIA) stock surged 11.2% in pre-market trading after the company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

The latest health updates include Centene's improved profitability forecast, US-initiated healthcare data-sharing plans ...

Investing.com -- Entera Bio Ltd (NASDAQ: ENTX) stock jumped 9.1% in pre-market trading after the FDA agreed that the company’s New Drug Application (NDA) for EB613 could use bone mineral density (BMD) ...

Digital tools can help amid manpower shortage at public health institutions. Read more at straitstimes.com. Read more at ...

Hims & Hers remains a compelling long-term play, with a resilient subscription-driven model, 85%+ retention, and 2.4 million ...

Eli Lilly and Company (NYSE:LLY) is one of the top low volatility healthcare stocks to buy now. On July 10, Morgan Stanley ...

Shares in nuclear medicine play Clarity Pharmaceuticals have surged up to 12% after the company's swift and supersized $203 ...

Investing.com -- Celcuity Inc. (NASDAQ: CELC) stock surged over 100% following the announcement of positive Phase 3 trial results for its breast cancer drug gedatolisib, which showed unprecedented ...

Nutraceutical and wellness-use cannabis includes cannabis-based products designed to support health, nutrition, and overall wellness without ...